Research News and Research

RSS

Sperm genes may have a detrimental effect on longevity, says new study

Researchers in Japan have found that female mice produced by using genetic material from two mothers but no father live significantly longer than mice with the normal mix of maternal and paternal genes. Their findings provide the first evidence that sperm genes may have a detrimental effect on lifespan in mammals.

1 Dec 2009

Chembio Diagnostics donates over 4,500 HIV test kits for the 2009 Testing Millions Global Campaign

Chembio Diagnostics, Inc., a NY-based company that develops, manufactures, licenses and markets proprietary rapid diagnostic tests, is donating more than 4,500 rapid HIV test kits to the AIDS Healthcare Foundation's 2009 Testing Millions Global Campaign, based in Los Angeles, to commemorate World AIDS Day 2009 on December 1st.

1 Dec 2009

CHS introduces the Optic onsite health care solution

Comprehensive Health Services, Inc. (CHS), a leading national workforce health management company specializing in onsite health care solutions, announced today the successful deployment of Optic™, the next iteration of its wireless, paperless technology platform that provides electronic health record and enterprise practice management functionality, predictive modeling, clinical reporting, evidence-based medicine compliance reporting, and advanced financial outcome reporting.

1 Dec 2009

MDK to distribute China Sky One Medical's AMI Diagnostic Kit and Human Urinary Albumin Elisa Kit

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company developing and producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that the Company has engaged Guangdong Mediacy Kind Medical Devices Industry Service Company ("MDK") to serve as its exclusive sales agent for the Company's AMI Diagnostic Kit and Human Urinary Albumin Elisa Kit in Southeast Asia.

1 Dec 2009

Teva Pharmaceutical Industries submits a BLA for its G-CSF XM02

Teva Pharmaceutical Industries Ltd., today announced the submission of a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for XM02, a granulocyte colony-stimulating factor (G-CSF) for the reduction in the duration of severe neutropenia and the incidence of febrile neutropenia in patients treated with established myelosuppressive chemotherapy for cancer.

1 Dec 2009

Calistoga Pharmaceuticals to present data on its CAL-101 inhibitor at the 51st ASH meeting

Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced that clinical and preclinical data supporting the role of CAL-101, an oral, p110δ(delta) selective PI3K inhibitor in patients with hematologic malignancies, will be featured in two oral presentations at the upcoming 51st American Society of Hematology (ASH) Annual Meeting taking place in New Orleans, LA.

1 Dec 2009

Roche's MagNA Pure 96 System for nucleic acid purification evaluated

TriCore Reference Laboratories of Albuquerque, N.M., reported at a recent user meeting results of their research collaboration with Roche Applied Science in which they evaluated Roche´s new MagNA Pure 96 System for use in nucleic acid purification. The evaluation focused on the Roche system’s ability to process specimens for pathogen testing.

1 Dec 2009

Palatin Technologies issued U.S. patent covering its lead heart failure drug candidate

Palatin Technologies, Inc. today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,622,440, titled "Cyclic Natriuretic Peptide Constructs." The claims in the issued patent cover a family of cyclic compounds that bind to natriuretic peptide receptor A (NPRA), including PL-3994, Palatin's lead heart failure drug candidate.

1 Dec 2009

NIH Library subscribes to Computable Genomix' GeneIndexer

Memphis-based Computable Genomix today announced that the National Institutes of Health Library has purchased a subscription to its premier product, GeneIndexer, an online genomics research tool.

1 Dec 2009

Chinese SFDA approves Tianyin Pharmaceutical's Pediatric Fever and Cough Oral Liquid

Tianyin Pharmaceutical Co., Inc.,, a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that it has received approvals from the Chinese State Food and Drug Administration (SFDA) to produce Pediatric Fever and Cough Oral Liquid in dosage form of 10 ml/tube (SFDA approval number Z20093060) and Antibacterial and Anti-inflammatory Capsules in dosage form of 0.27 gram/capsule (SFDA approval number Z20090855).

1 Dec 2009

Drug risk disclosures not read due to information overload, condensed version needed

When it comes to risk disclosures made by drug companies in print and television ads, many consumers are not paying attention, according to a recent study by ORC Guideline (an infoGROUP company). The latest study in the company’s Under the Skin series found that 41% of US consumers pay little or no attention to risk information presented by pharmaceutical companies in their TV commercials, and only half (50%) pay attention to such disclosures in print ads. This lack of attention is most prevalent among those 55 years of age or older.

1 Dec 2009

Royal Philips Electronics highlights its interventional radiology/oncology solutions at the RSNA meeting

On display at this year's Radiological Society of North America (RSNA) annual meeting, Royal Philips Electronics is highlighting its portfolio in the field of interventional radiology/oncology. The company is developing innovative image-guidance technologies for increasing the range and quality of minimally-invasive interventions and therapies.

From Philips Healthcare 1 Dec 2009

FORMA Therapeutics closes Series B financing to a total of $25.5 million

FORMA Therapeutics today announced that it has closed on a Series B financing that raised a total of $25.5 million. The round was led by new investor Lilly Ventures, with participation from existing investors Novartis Option Fund and Bio*One Capital of Singapore.

1 Dec 2009

Human-animal bond offers significant benefits

A pet owner knows the enormous joy and comfort that an animal can provide, especially in troubled times. Most pets are considered important members of the family and irreplaceable companions.

1 Dec 2009

Optoacoustics' FOMRI-III optical microphone now available for use in fMRI environments

Optoacoustics has announced availability of the FOMRI-III(TM) dual channel microphone, the most advanced optical microphone available for use in functional magnetic resonance imaging (fMRI) environments.

1 Dec 2009

New figures show steady decline in European cancer deaths, but variations exist between gender and countries

New figures show there was a steady decline in cancer deaths in the European Union between 1990-1994 and 2000-2004.

1 Dec 2009

New form of pathogen becomes a healthcare challenge in Africa

Research shows how a new, more deadly strain of Salmonella emerged over an 18-month period. Becoming resistant to antibiotics, acquiring the ability to spread from person to person and losing genes along the way, the new strain has become a healthcare challenge in Africa, killing up to one in four patients.

1 Dec 2009

Free medications to people after heart attack will increase length of their life

Providing free medications to people after heart attack could add years to patients' lives at a relatively low cost for provincial governments, according to a new study by researchers at St. Michael's Hospital in Toronto.

1 Dec 2009

Bayer Schering Pharma to develop new BiTE antibody for treatment of solid tumors

Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases today announced that Bayer Schering Pharma AG has exercised its option under the option, collaboration and license agreement entered into on January 12, 2009 to develop a new BiTE antibody for the treatment of solid tumors.

1 Dec 2009

Majority of Canadians join global charity event to raise awareness on prostate cancer

Movember, the month formerly known as November, is proud to share that 35,068 Canadians across the country joined the movement by growing a Mo (slang for moustache) and supporting men's health issues. This year over $6.3 million has been raised for Prostate Cancer Canada, with funds continuing to pour in.

1 Dec 2009

Research News and Research

Sperm genes may have a detrimental effect on longevity, says new study

Chembio Diagnostics donates over 4,500 HIV test kits for the 2009 Testing Millions Global Campaign

CHS introduces the Optic onsite health care solution

MDK to distribute China Sky One Medical's AMI Diagnostic Kit and Human Urinary Albumin Elisa Kit

Teva Pharmaceutical Industries submits a BLA for its G-CSF XM02

Calistoga Pharmaceuticals to present data on its CAL-101 inhibitor at the 51st ASH meeting

Roche's MagNA Pure 96 System for nucleic acid purification evaluated

Palatin Technologies issued U.S. patent covering its lead heart failure drug candidate

NIH Library subscribes to Computable Genomix' GeneIndexer

Chinese SFDA approves Tianyin Pharmaceutical's Pediatric Fever and Cough Oral Liquid

Drug risk disclosures not read due to information overload, condensed version needed

Royal Philips Electronics highlights its interventional radiology/oncology solutions at the RSNA meeting

FORMA Therapeutics closes Series B financing to a total of $25.5 million

Human-animal bond offers significant benefits

Optoacoustics' FOMRI-III optical microphone now available for use in fMRI environments

New figures show steady decline in European cancer deaths, but variations exist between gender and countries

New form of pathogen becomes a healthcare challenge in Africa

Free medications to people after heart attack will increase length of their life

Bayer Schering Pharma to develop new BiTE antibody for treatment of solid tumors

Majority of Canadians join global charity event to raise awareness on prostate cancer

A guide to advancing biotherapeutic research eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News